How to Treat a Male UTI: Antibiotics and Pain Relief

Male urinary tract infections are treated primarily with antibiotics, typically for seven days or longer depending on whether the infection has spread beyond the bladder. Because UTIs in men are relatively uncommon compared to women, clinicians generally treat them as “complicated” infections from the start, meaning a urine culture is standard and the choice of antibiotic is adjusted once lab results come back. Pain relief during the first couple of days, usually with phenazopyridine or over-the-counter anti-inflammatories, can make the wait for antibiotics to kick in much more bearable.

Why Male UTIs Get Extra Attention

In clinical terms, virtually all UTIs in men are classified as complicated. That label does not mean the infection is severe; it means the patient belongs to a group with a higher risk of treatment failure or hidden underlying causes. Men, pregnant women, immunocompromised patients, and anyone with a structural or functional abnormality of the urinary tract all fall into this category.¹ The reasoning is straightforward: the male urethra is longer and the prostate sits right at the base of the bladder, so when bacteria do manage to establish an infection, something is often helping them along. Conditions like bladder outlet obstruction, an enlarged prostate, kidney stones, catheter use, diabetes, or a weakened immune system all raise the odds of acquiring the infection and of it resisting treatment.²

This classification matters practically because it changes the diagnostic and treatment approach. Where a young woman with a straightforward bladder infection might receive a short course of antibiotics without a culture, a man with the same symptoms will almost always have a urine sample sent for culture and sensitivity testing.¹ That culture identifies the specific bacterium and which antibiotics it responds to, so the initial “best guess” prescription can be swapped if needed.

Getting the Diagnosis Right

If you have burning with urination, an urgent and frequent need to go, pelvic discomfort, or cloudy and foul-smelling urine, a dipstick urinalysis or microscopic exam is the first step. When the result is positive, your doctor should start empiric antibiotics right away while also sending a urine culture to confirm the diagnosis and fine-tune drug selection.³ Culture results usually come back within two to three days. If the bacterium turns out to be resistant to the antibiotic you started on, your prescription gets changed.

Because uncomplicated UTIs in men are genuinely rare, doctors are also thinking about what caused the infection. Imaging studies like ultrasound or CT should be considered early to rule out underlying problems in the urinary tract, such as stones, obstruction, or incomplete bladder emptying.⁴ Imaging is not always done on a first, mild episode, but it becomes more important if treatment fails, symptoms are unusually severe, the infection recurs, or you have diabetes or a compromised immune system.⁵ CT and MRI are especially valuable for catching complications early and guiding treatment decisions if the infection moves beyond the bladder.⁶

It is also worth knowing that UTI symptoms in men can overlap with sexually transmitted infections. Urethritis caused by chlamydia, gonorrhea, or less common organisms can look very similar, producing pain or discharge. In younger, sexually active men especially, your doctor may test for these pathogens before settling on a UTI diagnosis.⁷

Which Antibiotics Are Used

The most commonly prescribed antibiotic classes for male UTIs are fluoroquinolones (like ciprofloxacin and levofloxacin) and trimethoprim-sulfamethoxazole (often called TMP-SMX or Bactrim). In one large outpatient database study, fluoroquinolones accounted for about 70% of prescriptions, followed by TMP-SMX at roughly 21%, with nitrofurantoin and beta-lactams making up the rest.⁸ The reason fluoroquinolones dominate male UTI treatment has a lot to do with anatomy: they penetrate prostate tissue and prostatic secretions far better than most alternatives, which matters because even a “simple” bladder infection in a man may involve the prostate to some degree.⁹

That said, fluoroquinolones carry real side-effect risks, including tendon damage, nerve problems, and mood changes, which prompted an FDA boxed warning. Trimethoprim-sulfamethoxazole is a reasonable alternative for straightforward lower-tract infections and also reaches effective concentrations in prostate tissue and urine, though it does not penetrate prostatic secretions as thoroughly as fluoroquinolones.¹⁰ Nitrofurantoin works well for lower urinary tract infections confined to the bladder, but it does not reach useful concentrations in the prostate or kidneys, so it is a poor choice if there is any suspicion the infection extends beyond the bladder. Beta-lactams generally penetrate prostate tissue poorly unless there is active inflammation.⁹

One antibiotic worth flagging is fosfomycin. It reaches therapeutic levels in prostate tissue, prostatic secretions, seminal fluid, bladder tissue, and urine, giving it a broader tissue-coverage profile than many alternatives.⁹ In regions where fluoroquinolone resistance is high, fosfomycin is increasingly considered as a treatment option.

How Long Should You Take Antibiotics

The traditional recommendation for male UTIs has been a longer course than what women receive, often 10 to 14 days. But the evidence for that longer duration is thin. A large outpatient study comparing courses of seven days or fewer against longer courses found no clinical benefit to extending treatment beyond a week. In fact, among men without complicating urological conditions like an enlarged prostate or kidney stones, longer courses were associated with a higher rate of recurrence, not a lower one.⁸ The choice of antibiotic class itself did not affect recurrence rates in that same study, suggesting that finishing the infection matters more than which drug you use, as long as the bacterium is susceptible to it.

The exception is when the prostate is clearly involved. Acute bacterial prostatitis, which typically presents with fever, chills, and severe pelvic pain on top of urinary symptoms, usually requires two to four weeks of antibiotics. Broad-spectrum agents like ciprofloxacin, ceftriaxone, or even intravenous piperacillin-tazobactam are first-line options for prostatitis, with cure rates in the range of 92% to 97% when the full course is completed.¹¹ Your doctor will generally determine whether prostatitis is likely based on your symptoms, a digital rectal exam, and sometimes a post-massage urine sample.

Managing Pain While Antibiotics Work

Antibiotics typically start easing UTI symptoms within one to two days, but those first 24 to 48 hours can be miserable. There are a few ways to make that window more tolerable.

Phenazopyridine (sold over the counter in the U.S. as AZO or Pyridium) is a bladder analgesic that numbs the lining of the urinary tract. In a randomized placebo-controlled trial, patients taking phenazopyridine reported significant improvement within six hours. General discomfort dropped by about 53% compared to roughly 29% in the placebo group, and pain during urination fell by about 57% versus 36% with placebo.¹² The drug turns your urine bright orange, which is harmless but will stain clothing and contact lenses. The recommended adult dose is 100 to 200 mg three times daily, and you should limit use to two days. Staying on it longer raises the risk of a rare but serious side effect called methemoglobinemia, in which the blood’s ability to carry oxygen is impaired.¹³ People with kidney problems are at higher risk and should generally avoid it.

Standard over-the-counter pain relievers like ibuprofen or naproxen can also help with the discomfort and any low-grade fever. A warm compress or heating pad on the lower abdomen or perineum (the area between the scrotum and rectum) provides simple but real relief, especially for the pelvic pressure that often accompanies a male UTI. None of these replace antibiotics; they just bridge the gap until the medication starts working.

Hydration Actually Helps

The advice to “drink lots of water” during a UTI is not just a folk remedy. Increased fluid intake reduces the concentration of bacteria in urine and increases voiding frequency, which physically flushes organisms out of the bladder. One study on water loading in UTI patients found that bacterial counts dropped by about 2.5 log units within one to three hours, without a corresponding drop in the immune cells (neutrophils) that fight the infection. Raising urine volume also lowered osmolality and shifted pH in a way that made those neutrophils more effective at killing bacteria.¹⁴ The connection between fluid intake and UTI risk as a preventive measure is less settled, with experimental and clinical data still producing mixed results.¹⁵ Still, staying well-hydrated during an active infection makes physiological sense, and most clinicians recommend it.

When the Infection Spreads or Gets Complicated

A UTI that stays in the bladder is uncomfortable but manageable. The real concern is when bacteria climb to the kidneys (pyelonephritis), invade the bloodstream (urosepsis), or spread to the reproductive organs.

Pyelonephritis usually announces itself with flank pain, high fever, nausea, and sometimes rigors. It often requires intravenous antibiotics, at least initially. A retrospective study of patients treated for pyelonephritis or urosepsis found that receiving an aminoglycoside (gentamicin) as part of first-line treatment was associated with shorter IV treatment duration compared to regimens that did not include it.¹⁶ Once fever resolves and the patient can tolerate oral medications, treatment is typically switched to an oral antibiotic guided by culture results.

Epididymo-orchitis, an infection of the epididymis and testicle, is another complication that men should know about. In men over 35, it is most often caused by enteric organisms like E. coli, the same bacterium behind most UTIs, and is frequently linked to underlying bladder outlet obstruction or urethral narrowing. Fluoroquinolones have long been the go-to treatment, but rising ciprofloxacin resistance in E. coli strains is forcing clinicians to search for alternatives that still penetrate genital tissues well enough to clear the infection.¹⁷ In younger men, sexually transmitted organisms are the more likely culprits, and treatment is different accordingly.

Acute bacterial prostatitis, mentioned earlier, is itself a complication of UTI. The prostate can essentially harbor bacteria in a way that makes eradication harder. The gland’s tissue is difficult for many antibiotics to reach in therapeutic concentrations, which is why antibiotic choice matters so much when the prostate is involved.¹⁰

The Organisms Behind Male UTIs

Most UTIs, in men and women alike, are caused by Escherichia coli. A review in Nature Reviews Microbiology lists the usual suspects as E. coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis, and Staphylococcus saprophyticus.¹⁸ A hospital-based study found E. coli in about 55% of positive cultures, with Klebsiella species at about 10%, Pseudomonas at roughly 8%, and Enterococcus at about 9%.¹⁹ The distribution shifts in men with catheters or recent hospital stays, where Pseudomonas and Enterococcus become more common, and in prostatitis, where gram-negative bacteria like E. coli, Klebsiella, and Pseudomonas account for the overwhelming majority of cases.¹¹

Why does the specific organism matter to you? Because it dictates which antibiotic will work. Enterococcus, for instance, is inherently resistant to many cephalosporins and TMP-SMX, so a UTI caused by it needs a different drug. Pseudomonas is resistant to an even broader range of antibiotics. This is exactly why culture-guided treatment is the standard for men.

Catheter-Associated UTIs Are a Different Animal

If you have an indwelling urinary catheter, the rules change. Catheter-associated UTIs involve different organisms, different biofilm dynamics on the catheter surface, and a different clinical presentation compared to community-acquired infections. Treating them the same way as a standard UTI raises the risk of complications and treatment failure.²⁰ The general approach involves removing or replacing the catheter whenever possible, obtaining a fresh urine culture from the new catheter, and then using culture-guided antibiotics. Simply pouring antibiotics into a patient with a colonized catheter in place often does not resolve the infection because bacteria cling to the catheter surface in a biofilm that antibiotics struggle to penetrate.

Preventing Recurrence

For men who get recurrent UTIs, the most important step is identifying and treating the underlying cause. In many cases, that means addressing an enlarged prostate. Alpha-blockers like tamsulosin improve urine flow and reduce the amount of urine left in the bladder after voiding. In placebo-controlled research, alfuzosin reduced the incidence of acute urinary retention from about 2.4% with placebo to 0.4%.²¹ Better emptying means less stagnant urine for bacteria to colonize. Other medications for lower urinary tract symptoms, including 5-alpha-reductase inhibitors and phosphodiesterase-5 inhibitors, also improve symptom scores and can prevent worsening of urinary obstruction over time.²²

Methenamine hippurate is an old drug that has seen renewed interest as a non-antibiotic option for UTI prevention. It works by breaking down into formaldehyde in acidic urine, which kills bacteria. A Cochrane review found that it significantly reduced symptomatic UTIs in patients without structural abnormalities of the urinary tract, with a particularly strong effect during short-term use.²³ The catch: it did not show a benefit in patients with known renal tract abnormalities, and its usefulness around urological procedures like prostate surgery appears limited, probably because post-surgical catheter drainage prevents the sustained acidic urine exposure the drug needs to work.²⁴

What Antibiotics Do to Your Gut

One consequence of antibiotic treatment that rarely comes up in the doctor’s office is the collateral damage to your gut microbiome. A recent animal study measured the impact of UTI-specific antibiotic regimens on intestinal bacteria and found that treated animals showed a significant shift in their gut bacterial community compared to untreated controls. Bacterial richness and diversity dropped, with the treated group sharing fewer than 15% of bacterial types with the control group.²⁵ This is an animal model, not a direct human study, but the principle holds: the antibiotics that clear your UTI are not selective. They kill bacteria throughout your body, and your gut takes the hardest hit. This is one more reason not to extend antibiotic courses beyond what the evidence supports, and a reason to pay attention to diet and possibly probiotics during and after treatment. It also adds practical weight to the growing interest in non-antibiotic prevention strategies like methenamine hippurate for men prone to recurrent infections.

1
PubMed. Clinical Presentations and Epidemiology of Urinary Tract Infections
2
PubMed Central. Cross-sectional imaging of complicated urinary infections affecting the lower tract and male genital organs
3
BMJ Best Practice. Urinary tract infections in men
4
PubMed. The role of imaging in urinary tract infections
5
PubMed. Imaging of urinary tract infection in the adult
6
PubMed Central. CT and MRI in Urinary Tract Infections: A Spectrum of Different Imaging Findings
7
PubMed. Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan
8
PubMed Central. No Clinical Benefit to Treating Male Urinary Tract Infection Longer Than Seven Days: An Outpatient Database Study
9
PubMed. Antibiotic penetration in the male urinary tract: a critical review of pharmacokinetic and pharmacodynamic evidence
10
PubMed Central. Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Review
11
JAMA. Prostatitis: A Review
12
PubMed. Efficiency and safety of phenazopyridine for treatment of uncomplicated urinary tract infection: results of multi-center, randomized, placebo-controlled, clinical study
13
PubMed Central. Phenazopyridine-Induced Methaemoglobinaemia: The Aftermath of Dysuria Treatment
14
PubMed. Effect of alkalinisation and increased fluid intake on bacterial phagocytosis and killing in urine
15
European Journal of Clinical Nutrition. Mild dehydration: a risk factor of urinary tract infection?
16
PLOS ONE. The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study
17
PubMed. Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones
18
PubMed Central. Urinary tract infections: epidemiology, mechanisms of infection and treatment options
19
PubMed Central. Urinary tract infections: a retrospective, descriptive study of causative organisms and antimicrobial pattern of samples received for culture, from a tertiary care setting
20
PubMed Central. Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection
21
PubMed. Do alpha-blockers prevent the occurrence of acute urinary retention?
22
JAMA. Lower Urinary Tract Symptoms in Men: A Review
23
PubMed Central. Methenamine hippurate for preventing urinary tract infections
24
CMI Communications. Methenamine hippurate for prevention of urinary tract infections after endourological procedures: a systematic review
25
PubMed Central. Exploring the systemic impacts of urinary tract infection-specific antibiotic treatments on the gut microbiome, metabolome, and intestinal morphology in rats